Hisamitsu Pharmaceutical Co Performance
| HTSUFDelisted Stock | USD 30.31 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of -0.1, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Hisamitsu Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Hisamitsu Pharmaceutical is likely to outperform the market. Hisamitsu Pharmaceutical right now retains a risk of 0.0%. Please check out Hisamitsu Pharmaceutical treynor ratio and day median price , to decide if Hisamitsu Pharmaceutical will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Hisamitsu Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hisamitsu Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 91.4 B | |
| Total Cashflows From Investing Activities | -13.1 B |
Hisamitsu |
Hisamitsu Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 3,031 in Hisamitsu Pharmaceutical Co on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Hisamitsu Pharmaceutical Co or generate 0.0% return on investment over 90 days. Hisamitsu Pharmaceutical Co is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Hisamitsu, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hisamitsu Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hisamitsu Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Hisamitsu Pharmaceutical Co, and traders can use it to determine the average amount a Hisamitsu Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HTSUF |
Based on monthly moving average Hisamitsu Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hisamitsu Pharmaceutical by adding Hisamitsu Pharmaceutical to a well-diversified portfolio.
Hisamitsu Pharmaceutical Fundamentals Growth
Hisamitsu Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hisamitsu Pharmaceutical, and Hisamitsu Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hisamitsu Pink Sheet performance.
| Return On Equity | 0.0504 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.15 B | |||
| Shares Outstanding | 79.53 M | |||
| Price To Earning | 22.53 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 120.19 B | |||
| EBITDA | 17.3 B | |||
| Cash And Equivalents | 151.32 B | |||
| Total Debt | 219 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 3,393 X | |||
| Cash Flow From Operations | 19.2 B | |||
| Earnings Per Share | 1.06 X | |||
| Total Asset | 302.86 B | |||
| Retained Earnings | 216.56 B | |||
| Current Asset | 171.81 B | |||
| Current Liabilities | 37.93 B | |||
About Hisamitsu Pharmaceutical Performance
By analyzing Hisamitsu Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Hisamitsu Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hisamitsu Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hisamitsu Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2784 people.Things to note about Hisamitsu Pharmaceutical performance evaluation
Checking the ongoing alerts about Hisamitsu Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hisamitsu Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hisamitsu Pharmaceutical is not yet fully synchronised with the market data | |
| Hisamitsu Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| About 26.0% of the company shares are held by company insiders |
- Analyzing Hisamitsu Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hisamitsu Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Hisamitsu Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hisamitsu Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hisamitsu Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hisamitsu Pharmaceutical's pink sheet. These opinions can provide insight into Hisamitsu Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Hisamitsu Pink Sheet
If you are still planning to invest in Hisamitsu Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hisamitsu Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |